We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Should Bring Up Form 483 Disputes Early
Drugmakers Should Bring Up Form 483 Disputes Early
December 7, 2010
Manufacturers that disagree with inspection observations should make sure they bring it up before an investigator walks out the door, a former FDA official says.